What Is Premature Ejaculation (PE)?
Defining premature ejaculation is not always straightforward. One of the main reasons is that a satisfactory ejaculation time varies from person to person and depends on both individual and partner expectations. A duration that one man considers too short may be completely satisfactory for another. If you would like to learn more about premature ejaculation or discuss the most appropriate treatment options for your individual situation, please contact our clinic.
Prof. Dr. Şükrü Kumsar has over 20 years of experience in the diagnosis and treatment of premature ejaculation. Throughout his career, he has developed personalised medical and interventional treatment plans for thousands of patients. Using the latest evidence-based medical approaches, he creates an individualized treatment plan tailored to each patient’s specific needs.
İçerik
- What Is Premature Ejaculation (PE)?
- How Is Premature Ejaculation Clinically Defined?
- What Are the Symptoms of Premature Ejaculation?
- What Are the Types of Premature Ejaculation?
- What Causes Premature Ejaculation?
- Who Is at Greater Risk of Premature Ejaculation? (Risk Factors)
- How Is Premature Ejaculation Diagnosed?
- Treatment of Premature Ejaculation: Current Approaches
- Behavioral Therapy
- Pelvic Floor (Kegel) Exercises
- Psychological Support and Sex Therapy
- Medication for Premature Ejaculation
- Dapoxetine
- Other SSRIs
- Topical Treatments
- Can PDE5 Inhibitors Be Used to Treat Premature Ejaculation?
- Can Tramadol Be Used to Treat Premature Ejaculation?
- Glans Penis Augmentation
- Dorsal Nerve Cryotherapy
- Surgical Treatment (Dorsal Neurectomy)
- Other Sexual Dysfunction Conditions
Premature ejaculation (PE) is one of the most common male sexual dysfunctions. It is characterized by ejaculation occurring sooner than desired during sexual activity, accompanied by difficulty controlling ejaculation.
Premature ejaculation may be lifelong (primary) or acquired (secondary). The condition is not defined solely by ejaculation time but also by the individual’s inability to control ejaculation, the personal distress it causes, and its impact on the couple’s sexual relationship.
Current medical evidence shows that premature ejaculation may result from a combination of psychological, biological, neurological, hormonal, and genetic factors. Once an accurate diagnosis has been established, a range of effective treatment options is available, including behavioural therapy, medication, pelvic floor muscle exercises, topical treatments, and interventional procedures, depending on the patient’s individual needs.
Quick Facts
Premature ejaculation is not defined solely by how many minutes ejaculation takes. Current international guidelines emphasize that diagnosis should be based on ejaculation latency, the ability to control ejaculation, the level of personal distress, and the impact on the couple’s sexual relationship, rather than ejaculation time alone.
How Is Premature Ejaculation Clinically Defined?
The clinical definition of premature ejaculation (PE) has evolved over the years as different medical organizations have established diagnostic criteria. This is because premature ejaculation is a complex condition that cannot be defined by ejaculation time alone. Today, the most widely accepted approach considers ejaculation latency, the ability to control ejaculation, and the level of personal distress together when making the diagnosis.
According to the International Society for Sexual Medicine (ISSM), lifelong premature ejaculation is defined as ejaculation occurring before or within approximately one minute of vaginal penetration. In acquired premature ejaculation, the diagnosis is based on a clinically significant reduction in ejaculation latency compared with the individual’s previous sexual performance, typically to approximately three minutes or less. In both cases, loss of ejaculatory control and the distress caused by the condition are considered essential diagnostic criteria.
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) defines premature ejaculation as ejaculation occurring within approximately one minute after vaginal penetration during partnered sexual activity, present for at least six months, occurring in 75–100% of sexual encounters, and causing clinically significant distress.
In recent years, the European Association of Urology (EAU) has updated its approach by placing greater emphasis on loss of ejaculatory control and the patient’s distress, rather than focusing solely on a specific time threshold. This reflects the current understanding that premature ejaculation is not simply a condition measured by a stopwatch, but a multifactorial sexual dysfunction that should be evaluated comprehensively.
What Criteria Are Used to Diagnose Premature Ejaculation?
The diagnosis of premature ejaculation (PE) is not based solely on ejaculation time. An experienced urologist or andrologist evaluates several key factors together before making the diagnosis, including:
- Ejaculation occurring sooner than the individual desires
- Persistent difficulty delaying or controlling ejaculation
- Symptoms persisting for at least six months
- The condition occurring during most sexual encounters
- Significant distress, frustration, or relationship problems affecting the patient or their partner
- The absence of another underlying medical condition or medication that could explain the symptoms
A comprehensive assessment allows premature ejaculation to be accurately classified as lifelong (primary), acquired (secondary), variable, or subjective. This classification is essential for developing an individualized treatment plan tailored to each patient’s specific condition and needs.
Definition of Premature Ejaculation According to International Guidelines
| Guideline | Definition of Premature Ejaculation |
|---|---|
| ISSM | For lifelong premature ejaculation, ejaculation occurs before or within approximately 1 minute of vaginal penetration. For acquired premature ejaculation, there is a clinically significant reduction in ejaculation latency (typically ≤3 minutes), accompanied by loss of ejaculatory control and personal distress. |
| DSM-5 | Ejaculation occurs within approximately 1 minute after vaginal penetration, persists for at least 6 months, occurs in 75–100% of partnered sexual encounters, and causes clinically significant distress. |
| ICD-11 | Places greater emphasis on loss of ejaculatory control and the individual's personal distress rather than a specific time threshold. |
| EAU | Uses the term "premature ejaculation" and focuses primarily on loss of ejaculatory control and the patient's level of distress rather than ejaculation time alone. |
| AUA / SMSNA | Recommends diagnosing premature ejaculation based on both ejaculation latency and the patient's symptoms, concerns, and clinical assessment. |
What Are the Symptoms of Premature Ejaculation?
Premature ejaculation is not simply defined by a short duration of sexual intercourse. The primary problem is the inability to control ejaculation, resulting in sexual dissatisfaction for both the individual and their partner. In some men, the condition is present from their first sexual experiences, while in others it develops later in life.
According to international clinical guidelines, the diagnosis of premature ejaculation is based not only on ejaculation latency but also on loss of ejaculatory control, the personal distress it causes, and its impact on the couple’s sexual relationship.
Common Symptoms of Premature Ejaculation
- Involuntary ejaculation before or shortly after vaginal penetration
- Persistent difficulty delaying or controlling ejaculation
- The problem occurring during most sexual encounters
- Sexual intercourse lasting shorter than expected for the individual and their partner
- Development of performance anxiety
- Avoidance of sexual intimacy
- Reduced sexual confidence
- Decreased partner satisfaction
- Relationship stress and communication difficulties
- Reduced overall sexual satisfaction
Important Note
The diagnosis of premature ejaculation is not based solely on ejaculation time. Even if ejaculation occurs quickly, treatment may not be necessary if the individual is able to control ejaculation and does not experience personal distress. Conversely, some men may have a normal ejaculation time but still believe they ejaculate too early and experience significant anxiety. In such cases, a comprehensive medical evaluation is recommended to determine the underlying cause and the most appropriate management approach.
Don't delay, let's meet now !
- Feneryolu Bagdat Avenue No 85/1 Postal Code: 34724 Kadıköy/İstanbul - Turkey
| Type | Onset | Key Characteristics | Most Common Causes |
|---|---|---|---|
| Primary (Lifelong) | From the first sexual experience | Persistent throughout life | Biological factors such as genetic predisposition, neurobiological mechanisms, and penile hypersensitivity. |
| Secondary (Acquired) | Develops after a period of previously normal ejaculation | Occurs later in life | Erectile dysfunction, prostate disorders, hormonal changes, and psychological factors. |
| Variable | Occasional | Occurs during some sexual encounters but not others | Stress, fatigue, and relationship dynamics. |
| Subjective | May occur at any age | The individual perceives ejaculation as premature despite having a normal ejaculation time. | Performance anxiety and unrealistic expectations. |
What Are the Types of Premature Ejaculation?
Premature ejaculation is not a single condition. The most widely accepted classification today is the distinction between lifelong (primary) and acquired (secondary) premature ejaculation, as defined by the International Society for Sexual Medicine (ISSM). In addition, clinical subtypes such as variable and subjective premature ejaculation have also been described.
Comparison of the Types of Premature Ejaculation
| Type | Onset | Key Characteristics | Most Common Causes |
|---|---|---|---|
| Primary (Lifelong) |
From the first sexual experience | Persistent throughout life | Biological factors such as genetic predisposition, neurobiological mechanisms, and penile hypersensitivity |
| Secondary (Acquired) |
Develops after a period of previously normal ejaculation | Occurs later in life | Erectile dysfunction, prostate disorders, hormonal changes, and psychological factors |
| Variable | Occasional | Occurs during some sexual encounters but not others | Stress, fatigue, and relationship dynamics |
| Subjective | May occur at any age | The individual perceives ejaculation as premature despite having a normal ejaculation time | Performance anxiety and unrealistic expectations |
| Type of Premature Ejaculation | Definition and Characteristics |
|---|---|
| Primary (Lifelong) |
Primary premature ejaculation begins with the first sexual experience and persists throughout life. It is generally consistent across different partners and sexual situations. Biological mechanisms are thought to play a more prominent role in this type. Ongoing research has focused on the serotonin system, genetic predisposition, penile hypersensitivity, and the neurological mechanisms involved in the ejaculatory reflex. For most men with primary premature ejaculation, the condition is not simply a learned habit but is associated with the individual's innate ejaculatory mechanisms. Therefore, treatment should always be individualized. |
| Secondary (Acquired) |
Secondary premature ejaculation develops in men who previously had a normal ejaculation time. In this group, an underlying medical or psychological cause is more likely to be identified. The most common causes include:
In secondary premature ejaculation, treatments aimed solely at delaying ejaculation may not be sufficient. Identifying and treating the underlying cause can significantly improve treatment outcomes. Current European Association of Urology (EAU) guidelines also recommend evaluating associated conditions such as erectile dysfunction or prostate disease before planning treatment. |
| Variable |
Some men do not experience premature ejaculation during every sexual encounter. It may occur occasionally during periods of high stress, prolonged sexual abstinence, a new relationship, performance anxiety, or fatigue. This condition is referred to as variable premature ejaculation and usually does not require treatment. However, if it becomes persistent and begins to affect quality of life, medical evaluation is recommended. |
| Subjective |
In subjective premature ejaculation, the individual believes they ejaculate too early even though their ejaculation time is within the normal range. In most cases, the concern is related more to performance expectations or anxiety about satisfying a partner than to the actual ejaculation time. For these patients, education, sexual counselling, and psychological support, when appropriate, are important components of treatment. |
How Common Is Premature Ejaculation?
Premature ejaculation (PE) is one of the most common male sexual dysfunctions worldwide. However, determining its true prevalence is not as straightforward as it may seem. One of the main reasons is that different medical organizations use different diagnostic criteria, and research studies vary in their methodologies.
Published studies have reported prevalence rates ranging from 3% to 83%. This wide variation does not necessarily reflect true differences in how common the condition is. Instead, it is largely influenced by differences in diagnostic definitions, study design, cultural factors, and the way individuals perceive and report sexual health concerns.
Despite these variations, international clinical guidelines agree that premature ejaculation is a common condition affecting millions of men worldwide. Nevertheless, many men delay seeking medical advice because of embarrassment, reluctance to discuss sexual health, or a lack of awareness that effective treatment options are available. As a result, premature ejaculation may have a significant negative impact on both quality of life and relationship satisfaction.
Expert Opinion
Premature ejaculation is far more common than many people realize. However, not every episode of short-duration sexual intercourse should be considered premature ejaculation. Today, the diagnosis is based not only on ejaculation latency but also on the ability to control ejaculation, the level of personal distress, and the impact on the patient’s relationship, all of which should be assessed together as part of a comprehensive clinical evaluation.
What Causes Premature Ejaculation?
For many years, premature ejaculation (PE) was considered a sexual dysfunction caused primarily by psychological factors. However, scientific research over the past two decades has shown that premature ejaculation is not caused by a single factor. Instead, it is a multifactorial condition involving a combination of biological, neurological, hormonal, genetic, psychological, and relationship-related factors.
Today, it is well recognized that many men with premature ejaculation have underlying biological mechanisms such as abnormalities in the serotonin system, penile hypersensitivity, hormonal disorders, prostate diseases, or coexisting erectile dysfunction. At the same time, performance anxiety, stress, and relationship difficulties may significantly contribute to the condition in certain patients. Therefore, successful treatment should not focus solely on prolonging ejaculation time. Identifying and addressing the underlying cause is essential. Current international guidelines also recommend an individualized evaluation, with treatment tailored to the specific mechanisms contributing to each patient's condition.
Common Causes of Premature Ejaculation
| Cause | How It May Contribute to Premature Ejaculation |
|---|---|
| Psychological Factors | Performance anxiety, stress, depression, and relationship problems may negatively affect ejaculatory control. |
| Serotonin System Abnormalities | Alterations in brain serotonin levels and receptor function may accelerate the ejaculatory reflex. |
| Penile Hypersensitivity | Increased sensitivity of the glans penis may contribute to premature ejaculation. |
| Genetic Predisposition | Certain genetic variations may influence ejaculation latency. |
| Hormonal Disorders | Conditions such as hyperthyroidism have been associated with premature ejaculation. |
| Prostate Disorders | Chronic prostatitis and pelvic inflammation may contribute to premature ejaculation in some patients. |
| Erectile Dysfunction | Fear of losing an erection may lead to earlier ejaculation. |
| Neurological Mechanisms | Differences in the neural pathways regulating the ejaculatory reflex may play a role. |
| Diabetes and Obesity | Changes affecting the nervous system and blood vessels may increase the risk of premature ejaculation. |
| Vitamin Deficiencies | Some studies have reported an association between premature ejaculation and deficiencies of vitamin D and vitamin B12. |
Who Is at Greater Risk of Premature Ejaculation? (Risk Factors)
Premature ejaculation can affect men of any age. However, certain factors are associated with an increased risk of developing the condition.
Common Risk Factors
- Lifelong genetic predisposition
- Increased sensitivity of the glans penis (penile hypersensitivity)
- Performance anxiety
- High levels of stress
- Depression and anxiety disorders
- Erectile dysfunction
- Chronic prostatitis
- Hyperthyroidism
- Diabetes
- Obesity
- Traumatic sexual experiences
- Relationship problems
- Irregular sexual activity
The presence of one or more of these risk factors does not necessarily mean that premature ejaculation will develop. However, they provide important clinical information that should be considered during the evaluation and when planning the most appropriate treatment approach.
How Is Premature Ejaculation Diagnosed?
Diagnosing premature ejaculation is not always as simple as reaching a conclusion after a brief consultation. To develop an effective treatment plan, it is first necessary to determine whether the patient is truly experiencing premature ejaculation, identify the type of premature ejaculation involved, and assess any underlying causes.
Current international guidelines recommend that the diagnosis should primarily be based on the patient’s medical and sexual history, physical examination, and targeted investigations when clinically indicated. Routine laboratory tests or imaging studies are not recommended for every patient.
How Is the Diagnosis of Premature Ejaculation Made?
The diagnosis of premature ejaculation is not based on a single test. An experienced urologist or andrologist reaches a diagnosis by evaluating the relevant clinical steps together.
Acquired?
Treatment of Premature Ejaculation: Current Approaches
There is no single treatment that is appropriate for every patient. The most effective treatment plan is developed according to the following step-by-step approach.
Acquired?
When Needed
The goal of this treatment algorithm is not only to delay ejaculation but also to achieve long-term, sustainable improvement tailored to each patient's individual needs.
Behavioral Therapy
Behavioral techniques may be beneficial, particularly for men with mild to moderate premature ejaculation or when used in combination with medication. These approaches are designed to help patients recognize the ejaculatory reflex, improve control over ejaculation, and increase sexual awareness. Although they may not be sufficient as a standalone treatment for every patient, they can improve treatment outcomes when used in appropriately selected individuals.
| Start–Stop Technique | Squeeze Technique |
|---|---|
|
This is one of the oldest and most widely used behavioral techniques for the treatment of premature ejaculation. The goal is to help the individual recognize the sensation of impending ejaculation earlier and gradually develop better control over the ejaculatory reflex. |
The Squeeze Technique, originally described by Masters and Johnson, involves applying gentle pressure to the junction between the glans and the shaft of the penis for several seconds when ejaculation feels imminent. This temporary pressure may suppress the ejaculatory reflex and help prolong ejaculation latency. Both behavioral techniques may be beneficial for some patients when practiced regularly. However, current evidence suggests that behavioral therapy alone has limited effectiveness, and it is often recommended in combination with medication or other treatment options. |
Pelvic Floor (Kegel) Exercises
The pelvic floor muscles play an important role in both urinary control and the ejaculation process. Strengthening and properly activating these muscles may help improve ejaculatory control in some men.
Regular pelvic floor muscle training may be particularly beneficial for patients who have difficulty properly engaging these muscles, potentially leading to better control over ejaculation.
How to Perform Kegel Exercises
- Identify the muscles you use to stop the flow of urine.
- Tighten these muscles for 5 seconds.
- Relax them for 5 seconds.
- Repeat this cycle 10–15 times.
- Perform 2–3 sets daily on a regular basis.
During the exercise, it is important to contract only the pelvic floor muscles and avoid tightening the abdominal, buttock, or leg muscles.
Clinical Insight
Kegel exercises may not be sufficient as a standalone treatment for every patient. However, when combined with behavioral therapy and medical treatment, they may help improve ejaculatory control and enhance overall treatment outcomes.
Psychological Support and Sex Therapy
Although premature ejaculation is not always caused by psychological factors, emotional and psychological issues can increase the severity of the condition and negatively affect treatment outcomes.
Psychological support or sex therapy may be beneficial in the following situations:
- Performance anxiety
- Fear related to early sexual experiences
- Depression
- Anxiety disorders
- Relationship difficulties
- Communication problems between partners
Current recommendations from the International Society for Sexual Medicine (ISSM) and the Società Italiana di Andrologia e Medicina della Sessualità (SIAMS) suggest that, particularly in patients with a significant psychological component, combining behavioral and psychological interventions with pharmacological treatment may improve treatment outcomes.
Medication for Premature Ejaculation
The goal of medication for premature ejaculation (PE) is to prolong ejaculation latency and improve the patient's ability to control ejaculation.
Not every medication is suitable for every patient. Therefore, treatment should always be individualized and prescribed only after a comprehensive evaluation by a qualified physician.
According to current international clinical guidelines, the medications with the strongest scientific evidence for the treatment of premature ejaculation are dapoxetine and topical lidocaine/prilocaine formulations.
Dapoxetine
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) specifically developed for the treatment of premature ejaculation (PE). It is typically taken 1–3 hours before sexual activity. Due to its rapid absorption and short half-life, it is intended for on-demand use and does not require continuous daily administration.
Clinical studies have shown that dapoxetine can significantly increase intravaginal ejaculation latency time (IELT) and improve ejaculatory control. Treatment outcomes are generally more favorable when the medication is prescribed for appropriately selected patients and combined with regular clinical follow-up.
Other SSRIs
Other selective serotonin reuptake inhibitors (SSRIs), including paroxetine, sertraline, fluoxetine, as well as the tricyclic antidepressant clomipramine, may also be used in selected patients. However, most of these medications are prescribed off-label for the treatment of premature ejaculation.
When selecting the most appropriate medication, physicians should consider not only its potential effectiveness but also possible side effects, coexisting medical conditions, and any other medications the patient is currently taking.
Topical Treatments
Topical treatments are designed to temporarily reduce the sensitivity of the glans penis, thereby delaying the ejaculatory reflex. This approach may be particularly beneficial for men with increased penile sensitivity. Commonly used products include creams and sprays containing lidocaine or a combination of lidocaine/prilocaine.
| Advantages | Disadvantages |
|---|---|
|
|
Is Lidocaine/Prilocaine Spray Effective for Premature Ejaculation?
Topical lidocaine/prilocaine spray is a local treatment option designed to temporarily reduce the sensitivity of the glans penis, thereby delaying the ejaculatory reflex.
It is among the topical treatments approved in Europe for the management of lifelong premature ejaculation. Its effectiveness is based on temporarily reducing stimulation of the nerve endings in the glans penis.
It is generally applied approximately 5 minutes before sexual activity, and the recommended dosage should always follow the manufacturer's instructions. Clinical studies have shown that lidocaine/prilocaine spray can significantly increase intravaginal ejaculation latency time (IELT) and improve ejaculatory control.
| Advantages | Potential Disadvantages |
|---|---|
|
|
Important: In couples planning pregnancy or in situations where transfer of the medication to the partner may be a concern, the method of application should always follow the recommendations of a qualified physician.
Can PDE5 Inhibitors Be Used to Treat Premature Ejaculation?
PDE5 inhibitors, such as sildenafil and tadalafil, were not developed specifically to treat premature ejaculation (PE). However, they may be an important treatment option for men who experience premature ejaculation together with erectile dysfunction (ED).
Although PDE5 inhibitors alone do not appear to significantly prolong ejaculation latency, they may improve erectile function, reduce performance anxiety, and enhance a patient's sense of control over ejaculation.
Several clinical studies have shown that combining a PDE5 inhibitor with medications such as dapoxetine may improve both intravaginal ejaculation latency time (IELT) and overall patient satisfaction. For this reason, current international clinical guidelines recommend considering combination therapy, particularly for appropriately selected patients with coexisting erectile dysfunction.
Can Tramadol Be Used to Treat Premature Ejaculation?
Tramadol is an analgesic primarily used to treat pain. However, because it affects both serotonin and norepinephrine pathways, it may also delay ejaculation in some patients. Despite this potential benefit, tramadol is not considered a first-line treatment for premature ejaculation due to its risk of dependence and potential side effects. Current international clinical guidelines recommend that tramadol should be considered only in carefully selected patients when other treatment options are unsuitable or ineffective. Long-term or unsupervised use is not recommended.
When Is Combination Therapy Recommended?
In some patients, a single treatment approach may not be sufficient. Combination therapy can provide better outcomes, particularly when premature ejaculation is caused by multiple contributing factors.
Combination therapy may be considered in the following situations:
- Premature ejaculation associated with erectile dysfunction
- Insufficient response to behavioral therapy alone
- Inadequate improvement with a single medication
- Patients with significant penile hypersensitivity
Current international clinical guidelines suggest that, in appropriately selected patients, combining behavioral therapy, psychological support, and pharmacological treatment may improve treatment outcomes compared with a single treatment modality.
Glans Penis Augmentation
Hyaluronic acid (HA) injection into the glans penis is an interventional treatment that has gained increasing attention in recent years, particularly for carefully selected patients with pronounced glans penile hypersensitivity.
The primary goal of this procedure is to reduce the sensitivity of the glans penis, thereby improving ejaculatory control. However, this treatment is not suitable for every patient with premature ejaculation. Current international guidelines emphasize that, although early clinical studies have reported promising results, the overall level of scientific evidence remains limited. Therefore, glans augmentation should be considered only after careful patient selection and comprehensive clinical evaluation.
| Who May Be Suitable Candidates? | Who May Not Be Suitable Candidates? |
|---|---|
|
|
Dorsal Nerve Cryotherapy
Dorsal nerve cryotherapy is an interventional treatment that involves the controlled application of cold to selected branches of the dorsal penile nerve, with the aim of temporarily reducing nerve conduction.
The primary objective of this procedure is to decrease excessive sensory stimulation of the glans penis, thereby improving ejaculatory control.
Recent systematic reviews and meta-analyses have reported improvements in intravaginal ejaculation latency time (IELT) and patient satisfaction in carefully selected patients. However, the number of available studies remains limited, and further high-quality research is needed to establish the long-term effectiveness and safety of this treatment.
| Who May Be Considered for This Treatment? | Who May Not Be Suitable Candidates? |
|---|---|
|
|
Scientific Note
Dorsal nerve cryotherapy is one of the interventional treatments that has received increasing scientific attention in recent years. Nevertheless, additional high-quality studies involving larger patient populations are still required to better establish its long-term efficacy and safety.
Surgical Treatment (Dorsal Neurectomy)
Dorsal neurectomy is a surgical procedure that involves removing selected sensory branches of the dorsal penile nerve to reduce penile sensitivity. Men seeking a solution for premature ejaculation should first undergo a comprehensive evaluation by a urologist, preferably one with expertise in andrology. Because premature ejaculation has multiple potential causes, identifying the underlying mechanism is essential before considering any surgical intervention.
Dorsal neurectomy is not considered a first-line treatment for premature ejaculation. It may be considered only in carefully selected patients after a thorough clinical assessment and when conservative treatment options have failed or are deemed unsuitable. The potential benefits, limitations, and possible complications should always be discussed in detail with the treating physician before surgery.
What Does the Future Hold for the Treatment of Premature Ejaculation?
The treatment of premature ejaculation (PE) has evolved beyond improving existing medications. In recent years, considerable research has focused on the development of novel therapeutic agents and personalized treatment strategies aimed at improving treatment effectiveness while minimizing side effects.
Some of the most promising approaches currently under investigation include:
- Oxytocin receptor antagonists (Cligosiban and Epelsiban): These investigational drugs target alternative neurochemical pathways involved in the regulation of the ejaculatory reflex.
- Novel serotonin (5-HT) modulators: New compounds are being developed with the goal of providing a faster onset of action and a more favorable side-effect profile.
- Nanotechnology-based topical formulations: These formulations are designed to deliver medications in a controlled manner while reducing the risk of transferring the medication to a sexual partner.
- Personalized treatment approaches: Future treatment strategies may be tailored according to an individual's genetic profile and neurobiological characteristics, allowing for more precise and effective management of premature ejaculation.
Other Sexual Dysfunction Conditions
See All →
